A Taiwanese biotechnology company announced Monday that it has received a German company's authorization to sell a prospective COVID-19 vaccine that could be available as early as the first quarter of 2021.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Two Taiwan teams to play in 2024-25 East Asia Super League season
04/25/2024 04:21 PM - Science & Tech
TSMC unveils new A16 technology, aiming for production in 2026
04/25/2024 03:36 PM - Politics
Biden signs US$95 billion aid bill that includes funding for Taiwan defense
04/25/2024 02:58 PM - Cross-Strait
Newly-appointed Taiwan's top China affairs chief touted as 'pragmatic'
04/25/2024 02:50 PM - Politics
President-elect Lai names incoming national security team (update)
04/25/2024 02:42 PM